Laurent Audoly

Laurent Audoly is the current director at Ermium Therapeutics. Prior to this, they were with Parthenon Therapeutics, Cytovia Therapeutics, and Vanderbilt University School of Medicine. Laurent also has experience as an advisor, board member, president, and CEO with Atlas Venture and Kymera Therapeutics. In addition, they have also been a managing partner and founder with Pierre Fabre Fund for Innovation as well as an investment board member with Toulouse Tech Transfer. Lastly, they have also been an associate professor with Duke-NUS Graduate Medical School.

Laurent Audoly completed their PhD in pharmacology from Vanderbilt University School of Medicine. Laurent also has executive education from Harvard Kennedy School in investments and securities, as well as negotiation from Harvard Law School. In addition, they have a financial strategy certification from Harvard Business School. Finally, they have two certifications from Coursera in competitive strategy.